USFDA Woes Hit Lupin
  • WebDesk BTVI
  • Mar 14 2019

USFDA has classified inspection of the company's Mandideep (Unit 1) facility As OAI. USFDA has stated that facility may be subject to regulatory/administrative action. No new DMF & ANDA applications are pending review or approval from Mandideep facility.